IRLAB Therapeutics AB Market Cap

IRLAB Therapeutics AB has a market cap or net worth of 372.42 million as of May 13, 2025. Its market cap has decreased by -31.94% in one year.

Market Cap

372.42M

Enterprise Value

350.27M

Revenue

102.69M

Ranking

n/a

PE Ratio

n/a

Stock Price

7.29

Market Cap Chart

Since February 28, 2017, IRLAB Therapeutics AB's market cap has decreased from 413.00M to 372.42M, a decrease of -9.83%. That is a compound annual growth rate of -1.25%.

Market Cap History

Date	Market Cap	% Change
May 13, 2025	392.13M	-29.67%
Dec 30, 2024	557.59M	43.33%
Dec 29, 2023	389.01M	-80.42%
Dec 30, 2022	1.99B	-12.75%
Dec 30, 2021	2.28B	4.76%
Dec 30, 2020	2.17B	37.75%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Swedish Orphan Biovitrum AB	104.27B
Sectra AB	59.53B
Getinge AB	52.98B
Camurus AB	36.97B
Medicover AB	36.18B
AddLife AB	23.20B
Vitrolife AB	21.41B
Vimian Group AB	20.31B

Market Cap Rankings